Translink Corporate Finance advised WVT Group, on its acquisition of CYGYC BIOCON, a Spanish specialised multi-brand platform

Translink Corporate Finance™ in Spain acted as the financial advisor to WVT Group on its acquisition of CYGYC BIOCON, a Spanish specialised multi-brand platform that develops, manufactures and markets chemical specialties and biotechnological solutions.

WVT Group strengthens its European leadership in sustainable hygiene solutions with the acquisition of CYGYC BIOCON

CYGYC BIOCON, a fast-growing Spanish multi-brand platform combining specialty chemicals, probiotics and enzymatic products, has a presence in over 35 countries, and combines in-house R&D capabilities in enzyme development and formulation expertise that deliver high-performance and sustainable solutions. Its portfolio consists of four complementary brands across food & feed enzymes, detergency enzymes and professional detergents & disinfecting agents.

WVT Group is a pan-European leader in the development, production and commercialisation of mission critical detergents and disinfectants, supporting its customers across the industrial, maritime, food, professional hygiene, disinfection and biosecurity sectors. WVT Group provides tailored, sustainable and environmentally certified solutions.

This transaction marks the second transformative acquisition completed since Siparex ETI became WVT Group’s majority shareholder in 2025 and represents a significant step in WVT Group’s international growth strategy.

This acquisition brings complementary expertise in enzyme technology and in-house R&D to WVT Group, expanding the group’s product development capabilities across its core verticals. Beyond technology and market reach, CYGYC BIOCON’s balanced portfolio across chemicals, enzymes, and probiotics strengthens WVT Group’s ability to offer comprehensive, sustainable hygiene solutions to its customers. The combined group’s turnover will reach more than €100 million.

Comments from WVT Group

Ward Van Thielen, Founder of WVT Group, commented: “This acquisition is a major step in WVT Group’s development. CYGYC BIOCON’s expertise in enzyme technology and bio-solutions is a strong complement to what we have built over the past thirty years. Together, we will be able to offer our customers a broader and more innovative range of solutions, while accelerating our international expansion. Furthermore, CYGYC BIOCON is a family-owned company, a quality reflected in the strong shared values and entrepreneurial DNA it shares with WVT Group.”